LY 2584702
Alternative Names: LY-S6K1; LY2584702; LYS 6K1 tosylate; P70 inhibitorLatest Information Update: 02 Oct 2021
At a glance
- Originator Eli Lilly and Company
- Class Antineoplastics
- Mechanism of Action 70 kDa ribosomal protein S6 kinase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Solid tumours
Most Recent Events
- 10 Jan 2012 Discontinued - Phase-I for Solid tumours in France (PO)
- 10 Jan 2012 Discontinued - Phase-I for Solid tumours in Japan (PO)
- 10 Jan 2012 Discontinued - Phase-I for Solid tumours in Singapore (PO)